State Street Corp Zomedica Corp. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Zomedica Corp. stock. As of the latest transaction made, State Street Corp holds 3,916,781 shares of ZOM stock, worth $117,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,916,781

Previous 3,509,881 11.59%

Holding current value

$117,503

Previous $491,000 4.28%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.12 - $0.15 $48,828 - $61,035	406,900 Added 11.59%	3,916,781 $470,000
Q2 2024 Aug 14, 2024	BUY	$0.12 - $0.18 $47,916 - $71,874	399,300 Added 12.84%	3,509,881 $526,000
Q1 2024 May 15, 2024	SELL	$0.12 - $0.19 $25,332 - $40,109	-211,100 Reduced 6.36%	3,110,581 $466,000
Q1 2023 May 15, 2023	SELL	$0.16 - $0.29 $2,672 - $4,843	-16,700 Reduced 0.5%	3,321,681 $697,000
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.34 $3.08 Million - $5.23 Million	-15,379,313 Reduced 82.16%	3,338,381 $735,000
Q1 2022 May 16, 2022	SELL	$0.28 - $0.4 $2.8 Million - $4.01 Million	-10,012,508 Reduced 34.85%	18,717,694 $6.31 Million
Q4 2021 Feb 14, 2022	BUY	$0.31 - $0.58 $1.84 Million - $3.44 Million	5,932,371 Added 26.02%	28,730,202 $8.81 Million
Q3 2021 Nov 15, 2021	BUY	$0.46 - $0.81 $2.04 Million - $3.59 Million	4,431,423 Added 24.13%	22,797,831 $11.9 Million
Q2 2021 Aug 16, 2021	BUY	$0.72 - $1.46 $9.36 Million - $19 Million	12,993,071 Added 241.81%	18,366,408 $15.3 Million
Q1 2021 May 17, 2021	BUY	$0.35 - $2.7 $1.88 Million - $14.5 Million	5,373,337 New	5,373,337 $8.49 Million

Others Institutions Holding ZOM

# of Institutions

Shares Held

91.7M

Call Options Held

Put Options Held

View Full List

About Zomedica Corp.

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $29.4M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

More about ZOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Zomedica Corp. Transaction History